1 result

• Data Used To Approve Zolgensma Gene Therapy Treatment May Have Been Manipulated: FDA

  August 7, 2019

  Russell Maas

  The FDA says a Novartis subsidiary manipulated data in animal trials used to approve a gene therapy treatment for children, but will let the treatment, the most expensive in the world, stay on the market due to a lack of other treatment options.